Antioxidant action of 7,8-dihydroxyflavone protects PC12 cells against 6-hydroxydopamine-induced cytotoxicity

Neurochemistry International

Volumn 64, Issue 1, 2014, Pages 18-23

  Han, Xiaohua ^a   Zhu, Shaolei ^a   Wang, Bingxiang ^a   Chen, Lei ^a   Li, Ran ^a   Yao, Weicheng ^a   Qu, Zhiqiang ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

6 Hydroxydopamine; 7,8 Dihydroxyflavone; Antioxidant; Oxidative stress; PC12 cell; TrkB

Indexed keywords

7,8 DIHYDROXYFLAVONE; HISTONE H2AX; HYDROGEN PEROXIDE; MALONALDEHYDE; OXIDOPAMINE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; AUTOOXIDATION; BLOOD BRAIN BARRIER; CELL DEATH; CELL FREE SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PC12 CELL; PRIORITY JOURNAL; RAT;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; 6-HYDROXYDOPAMINE; 6-OHDA; 7,8-DHF; 7,8-DIHYDROXYFLAVONE; AD; ALZHEIMER'S DISEASE; AMERICAN TYPE CULTURE COLLECTION; ANOVA; ANTIOXIDANT; ATCC; DA; DIMETHYL SULFOXIDE; DMEM; DMSO; DOPAMINE; DULBECCO'S MODIFIED EAGLE'S MEDIUM; ECL; ENHANCED CHEMILUMINESCENCE; FCS; FETAL CALF SERUM; H(2)O(2); HORSERADISH PEROXIDASE; HRP; HYDROGEN PEROXIDE; MALONDIALDEHYDE; MDA; MPTP; MTT; ONE-WAY ANALYSIS OF VARIANCE; OXIDATIVE STRESS; P-H2A.X; PARKINSON'S DISEASE; PC12 CELL; PD; PHOSPHO-HISTONE H2A.X; REACTIVE OXYGEN SPECIES; RH123; RHODAMINE 123; ROS; SDS; SOD; SODIUM DODECYL SULFATE; SUPEROXIDE DISMUTASE; TH; THIAZOLYL BLUE TETRAZOLIUM BROMIDE; TRKB; TYROSINE HYDROXYLASE; TYROSINE KINASE RECEPTOR B;

ANIMALS; ANTIOXIDANTS; CELL DEATH; CELL LINE; FLAVONES; HYDROGEN PEROXIDE; HYDROXYDOPAMINES; NEURODEGENERATIVE DISEASES; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PC12 CELLS; RATS; REACTIVE OXYGEN SPECIES;

EID: 84888235110     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2013.10.018     Document Type: Article

References (29)

1. J.K. Andersen Oxidative stress in neurodegeneration: cause or consequence? Nat. Med. 10 Suppl. 2004 S18 S25
2. M.F. Beal Experimental models of Parkinson's disease Nat. Rev. Neurosci. 2 2001 325 334
3. J. Chen, K.W. Chua, C.C. Chua, H. Yu, A. Pei, B.H. Chua, R.C. Hamdy, X. Xu, and C.F. Liu Antioxidant activity of 7,8-dihydroxyflavone provides neuroprotection against glutamate-induced toxicity Neurosci. Lett. 499 2011 181 185
4. L. Devi, and M. Ohno 7,8-Dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease Neuropsychopharmacology 37 2012 434 444
5. W.G. Duan, J. Shang, Z.Z. Jiang, J.C. Yao, Y. Yun, M. Yan, B. Shu, Q. Lin, Z.P. Yu, and L.Y. Zhang Rho kinase inhibitor Y-27632 down-regulates norepinephrine synthesis and release in PC12 cells Basic Clin. Pharmacol. Toxicol. 104 2009 434 440
6. T. Fernandes-Alnemri, G. Litwack, and E.S. Alnemri CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme J. Biol. Chem. 269 1994 30761 30764
7. H. Fujita, T. Ogino, H. Kobuchi, T. Fujiwara, H. Yano, J. Akiyama, K. Utsumi, and J. Sasaki Cell-permeable cAMP analog suppresses 6-hydroxydopamine- induced apoptosis in PC12 cells through the activation of the Akt pathway Brain Res. 1113 2006 10 23
8. M. Gerlach, and P. Riederer Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man J. Neural Transm. 103 1996 987 1041
9. D.R. Green, and J.C. Reed Mitochondria and apoptosis Science 281 1998 1309 1312
10. V.K. Gupta, Y. You, J.C. Li, A. Klistorner, and S.L. Graham Protective effects of 7,8-dihydroxyflavone on retinal ganglion and RGC-5 cells against excitotoxic and oxidative stress J. Mol. Neurosci. 49 2013 96 104
11. B. Halliwell Oxidative stress and neurodegeneration: where are we now? J. Neurochem. 97 2006 1634 1658
12. J.H. Jang, O.I. Aruoma, L.S. Jen, H.Y. Chung, and Y.J. Surh Ergothioneine rescues PC12 cells from beta-amyloid-induced apoptotic death Free Radical Biol. Med. 36 2004 288 299
13. W. Jang, X. Liu, M. Yepes, K.R. Shepherd, G.W. Miller, Y. Liu, W.D. Wilson, G. Xiao, B. Blanchi, Y.E. Sun, and K. Ye A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone Proc. Natl. Acad. Sci. USA 107 2010 2687 2692
14. L.M. de Lau, and M.M. Breteler Epidemiology of Parkinson's disease Lancet Neurol. 5 2006 525 535
15. C.S. Lee, J.H. Han, Y.Y. Jang, J.H. Song, and E.S. Han Differential effect of catecholamines and MPP(+) on membrane permeability in brain mitochondria and cell viability in PC12 cells Neurochem. Int. 40 2002 361 369
16. W. Linert, E. Herlinger, R.F. Jameson, E. Kienzl, K. Jellinger, and M.B. Youdim Dopamine, 6-hydroxydopamine, iron, and dioxygen-their mutual interactions and possible implication in the development of Parkinson's disease Biochim. Biophys. Acta 1316 1996 160 168
17. J. Lotharius, and P. Brundin Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein Nat. Rev. Neurosci. 3 2002 932 942
18. S.A. Mandel, T. Amit, O. Weinreb, L. Reznichenko, and M.B. Youdim Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseases CNS Neurosci. Ther. 14 2008 352 365
19. M. Melidou, K. Riganakos, and D. Galaris Protection against nuclear DNA damage offered by flavonoids in cells exposed to hydrogen peroxide: the role of iron chelation Free Radical Biol. Med. 39 2005 1591 1600
20. A.I. Rojo, M. Salinas, D. Martín, R. Perona, and A. Cuadrado Regulation of Cu/Zn-superoxide dismutase expression via the phosphatidylinositol 3 kinase/Aktpathway and nuclear factor-kappaB J. Neurosci. 24 2004 7324 7334
21. Y. Saito, K. Nishio, Y. Ogawa, T. Kinumi, Y. Yoshida, Y. Masuo, and E. Niki Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: involvement of hydrogen peroxide-dependent and -independent action Free Radical Biol. Med. 42 2007 675 685
22. R. Soto-Otero, E. Méndez-Alvarez, A. Hermida-Ameijeiras, A.M. Muñoz-Patiño, and J.L. Labandeira-Garcia Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease J. Neurochem. 74 2000 1605 1612
23. J.P. Spencer Flavonoids and brain health: multiple effects underpinned by common mechanisms Genes Nutr. 4 2009 243 250
24. S. Surendran, and S. Rajasankar Parkinson's disease: oxidative stress and therapeutic approaches Neurol. Sci. 31 2010 531 540
25. L. Tao, X. Li, L. Zhang, J. Tian, X. Li, X. Sun, X. Li, L. Jiang, X. Zhang, and J. Chen Protective effect of tetrahydroxystilbene glucoside on 6-OHDA-induced apoptosis in PC12 cells through the ROS-NO pathway PLoS One 6 2011 e26055
26. J. Wang, X.X. Du, H. Jiang, and J.X. Xie Curcumin attenuates 6-hydroxydopamine-induced cytotoxicity by anti-oxidation and nuclear factor-kappa B modulation in MES23.5 cells Biochem. Pharmacol. 78 2009 178 183
27. A.S. Woldu, and J. Mai A novel relationship between the radical-scavenging activity of flavonoids and enthalpy of formation revealed with Hartree-Fock computations and thermochemical deduction Redox Rep. 17 2012 115 130
28. J. Yuan, R. Adamski, and J. Chen Focus on histone variant H2AX: to be or not to be FEBS Lett. 10 584 2010 3717 3724
29. R. Zhang, K.A. Kang, M.J. Piao, D.O. Ko, Z.H. Wang, W.Y. Chang, H.J. You, I.K. Lee, B.J. Kim, S.S. Kang, and J.W. Hyun Preventive effect of 7,8-dihydroxyflavone against oxidative stress induced genotoxicity Biol. Pharm. Bull. 32 2009 166 171